Bunge Global SA (BG)
Official siteCONSUMER DEFENSIVE • FARM PRODUCTS • NYSE
Market Cap: $19.53B
Last updated: Nov 17, 2026 at 11:04 AM ET
Bunge Global SA (BG) Financials: Revenue, Profit and Cash Flow
Bunge Global SA reported revenue of $70.33B for the fiscal year ended Dec 31, 2025, up 32.4% from the year before. That year, net income was $843.00M with a net margin of 1.2%, operating cash flow was $844.00M and free cash flow was -$879.00M. The quarter ended Sep 30, 2026 had revenue of $23.80B and net income of $347.00M.
Revenue and Margins
The operating margin was 1.8% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $42.68B, a compound annual rate of 5.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $70.33B | +32.4% | 4.8% | 1.8% | 1.2% |
| Dec 2024 | $53.11B | -10.8% | 6.4% | 3.0% | 2.2% |
| Dec 2023 | $59.54B | -11.4% | 8.1% | 5.3% | 3.9% |
| Dec 2022 | $67.23B | +13.7% | 5.5% | 3.4% | 2.5% |
| Dec 2021 | $59.15B | +42.9% | 5.7% | 3.6% | 3.5% |
| Dec 2020 | $41.40B | +0.6% | 6.7% | 3.4% | 2.8% |
| Dec 2019 | $41.14B | -10.1% | 1.3% | -2.0% | -3.1% |
| Dec 2018 | $45.74B | -0.1% | 5.0% | 1.8% | 0.6% |
| Dec 2017 | $45.79B | +7.3% | 3.9% | 0.7% | 0.3% |
| Dec 2016 | $42.68B | N/A | 5.6% | 2.6% | 1.7% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 29.2% from the year before. In the quarter ended Sep 2026, net income rose 91.7% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70.33B | $53.11B | $59.54B | $67.23B | $59.15B | $41.40B | $41.14B | $45.74B | $45.79B | $42.68B |
| Cost of revenue | $66.92B | $49.72B | $54.70B | $63.55B | $55.79B | $38.62B | $40.60B | $43.48B | $44.03B | $40.27B |
| Gross profit | $3.41B | $3.39B | $4.84B | $3.68B | $3.36B | $2.79B | $542.00M | $2.27B | $1.76B | $2.41B |
| Research and development | $0 | $0 | $0 | $0 | $33.00M | $24.00M | $15.00M | $15.00M | $20.00M | $17.00M |
| Operating income | $1.30B | $1.62B | $3.13B | $2.31B | $2.13B | $1.43B | -$809.00M | $843.00M | $328.00M | $1.13B |
| Net income | $843.00M | $1.19B | $2.34B | $1.68B | $2.08B | $1.15B | -$1.28B | $267.00M | $160.00M | $745.00M |
| EBITDA | $2.26B | $2.30B | $3.87B | $2.70B | $3.23B | $2.11B | -$318.00M | $1.42B | $1.10B | $1.78B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.80B | $24.04B | $21.86B | $23.76B | $22.16B | $12.77B | $11.64B | $13.54B | $12.91B | $13.24B | $13.42B | $14.94B |
| Gross profit | $1.33B | $1.68B | $766.00M | $1.01B | $1.06B | $738.00M | $597.00M | $1.08B | $772.00M | $664.00M | $876.00M | $1.25B |
| Operating income | $727.00M | $1.07B | $235.00M | $374.00M | $385.00M | $320.00M | $217.00M | $630.00M | $335.00M | $215.00M | $437.00M | $759.00M |
| Net income | $347.00M | $707.00M | $75.00M | $88.00M | $181.00M | $370.00M | $204.00M | $630.00M | $233.00M | $73.00M | $252.00M | $616.00M |
Balance Sheet
As of Dec 2025, total debt of $14.05B exceeded cash and equivalents by $12.92B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $44.53B | $24.90B | $25.37B | $24.58B | $23.82B | $23.66B | $18.32B | $19.43B | $18.87B | $19.19B |
| Current assets | $24.39B | $15.96B | $16.35B | $16.76B | $16.46B | $16.18B | $10.25B | $11.07B | $10.40B | $11.09B |
| Cash and equivalents | $1.14B | $3.31B | $2.60B | $1.10B | $902.00M | $352.00M | $320.00M | $389.00M | $601.00M | $934.00M |
| Total liabilities | $27.11B | $13.95B | $13.56B | $14.62B | $15.61B | $17.04B | $11.89B | $12.62B | $11.51B | $11.85B |
| Short-term debt | $5.22B | $1.54B | $1.11B | $1.82B | $1.53B | $3.07B | $1.49B | $1.17B | $634.00M | $1.72B |
| Long-term debt | $8.83B | $4.69B | $4.08B | $3.26B | $4.79B | $4.45B | $3.72B | $4.20B | $4.16B | $3.07B |
| Shareholder equity | $15.90B | $9.91B | $10.85B | $9.22B | $7.67B | $6.07B | $5.91B | $6.17B | $7.15B | $7.14B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $49.66B | $46.78B | $47.58B | $44.53B | $46.30B | $31.15B | $26.66B | $24.90B | $25.27B | $24.43B | $25.82B | $25.37B |
| Total liabilities | $31.78B | $29.37B | $30.10B | $27.11B | $29.01B | $19.20B | $15.07B | $13.95B | $14.11B | $13.44B | $14.29B | $13.56B |
| Cash and equivalents | $524.00M | $593.00M | $839.00M | $1.14B | $1.31B | $6.79B | $3.25B | $3.31B | $2.84B | $1.16B | $2.94B | $2.60B |
| Shareholder equity | $16.30B | $15.95B | $16.05B | $15.90B | $15.77B | $10.88B | $10.58B | $9.91B | $10.13B | $10.00B | $10.55B | $10.85B |
Cash Flow
In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $844.00M | $1.90B | $3.31B | -$5.55B | -$2.89B | -$3.54B | -$814.00M | -$1.26B | -$1.98B | $446.00M |
| Capital expenditures | $1.72B | $1.38B | $1.12B | $555.00M | $399.00M | $365.00M | $524.00M | $493.00M | $662.00M | $784.00M |
| Free cash flow | -$879.00M | $524.00M | $2.19B | -$6.10B | -$3.29B | -$3.90B | -$1.34B | -$1.76B | -$2.64B | -$338.00M |
| Dividends paid | $459.00M | $378.00M | $383.00M | $349.00M | $323.00M | $316.00M | $317.00M | $305.00M | $297.00M | $282.00M |
| Share repurchases | $569.00M | $1.10B | $600.00M | $302.00M | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | -$5.23B | -$1.11B | -$1.01B | $6.50B | $5.11B | $1.81B | $1.50B | $410.00M | -$1.16B | -$926.00M |
| Financing cash flow | $2.23B | -$90.00M | -$856.00M | -$769.00M | -$1.63B | $1.76B | -$745.00M | $631.00M | -$180.00M | -$488.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.18B | -$585.00M | -$541.00M | $1.35B | $854.00M | -$1.07B | -$285.00M | $1.05B | $1.33B | -$1.47B | $994.00M | $1.45B |
| Capital expenditures | $384.00M | $443.00M | $336.00M | $538.00M | $469.00M | $406.00M | $310.00M | $489.00M | $354.00M | $297.00M | $236.00M | $317.00M |
| Free cash flow | -$1.56B | -$1.03B | -$877.00M | $809.00M | $385.00M | -$1.48B | -$595.00M | $564.00M | $973.00M | -$1.77B | $758.00M | $1.13B |
Frequently Asked Questions About BG
What is Bunge Global SA's annual revenue?
Bunge Global SA reported revenue of $70.33B for the fiscal year ended Dec 31, 2025.
How fast is Bunge Global SA's revenue growing?
Revenue was up 32.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 1.5%.
Is Bunge Global SA profitable?
Yes. Bunge Global SA reported net income of $843.00M for the fiscal year ended Dec 31, 2025, with a net margin of 1.2%.
How much free cash flow does BG generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $844.00M minus capital expenditures of $1.72B produced free cash flow of -$879.00M.
How much debt does Bunge Global SA have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $8.83B, short-term debt of $5.22B and cash and equivalents of $1.14B.
BG pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors